On Tuesday, Dynavax Technologies Corp (NASDAQ: DVAX) was -4.17% drop from the session before settling in for the closing price of $14.39. A 52-week range for DVAX has been $9.74 – $14.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 177.58%. When this article was written, the company’s average yearly earnings per share was at 69.00%. With a float of $118.57 million, this company’s outstanding shares have now reached $125.45 million.
Considering the fact that the conglomerate employs 405 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 82.17%, operating margin of -0.75%, and the pretax margin is 11.13%.
Dynavax Technologies Corp (DVAX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dynavax Technologies Corp stocks. The insider ownership of Dynavax Technologies Corp is 4.43%, while institutional ownership is 101.94%. The most recent insider transaction that took place on Mar 07 ’25, was worth 471,474. In this transaction President & COO of this company sold 32,764 shares at a rate of $14.39, taking the stock ownership to the 22,098 shares. Before that another transaction happened on Mar 07 ’25, when Company’s Officer proposed sale 32,764 for $14.39, making the entire transaction worth $471,376.
Dynavax Technologies Corp (DVAX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 69.00% per share during the next fiscal year.
Dynavax Technologies Corp (NASDAQ: DVAX) Trading Performance Indicators
You can see what Dynavax Technologies Corp (DVAX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.17. Likewise, its price to free cash flow for the trailing twelve months is 28.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.17, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.56 in one year’s time.
Technical Analysis of Dynavax Technologies Corp (DVAX)
Compared to the last year’s volume of 2.26 million, its volume of 5.67 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 64.93%. Additionally, its Average True Range was 0.44.
During the past 100 days, Dynavax Technologies Corp’s (DVAX) raw stochastic average was set at 80.14%, which indicates a significant increase from 47.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.00% in the past 14 days, which was lower than the 32.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.08, while its 200-day Moving Average is $11.93. Nevertheless, the first resistance level for the watch stands at $14.19 in the near term. At $14.60, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.80. If the price goes on to break the first support level at $13.58, it is likely to go to the next support level at $13.38. Should the price break the second support level, the third support level stands at $12.97.
Dynavax Technologies Corp (NASDAQ: DVAX) Key Stats
There are 124,071K outstanding shares of the company, which has a market capitalization of 1.71 billion. As of now, sales total 277,250 K while income totals 27,310 K. Its latest quarter income was 72,030 K while its last quarter net income were 7,050 K.
